|
ACTR6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.37629999999945E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.394500E-04 |
| Normal-vs-Stage2 |
1.339400E-03 |
| Normal-vs-Stage3 |
1.96384999999744E-05 |
| Normal-vs-Stage4 |
7.31189999991777E-07 |
| Stage1-vs-Stage2 |
4.878400E-01 |
| Stage1-vs-Stage3 |
1.675400E-01 |
| Stage1-vs-Stage4 |
2.033600E-02 |
| Stage2-vs-Stage3 |
7.724600E-01 |
| Stage2-vs-Stage4 |
3.406400E-01 |
| Stage3-vs-Stage4 |
3.967200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.161730E-04 |
| Normal-vs-AfricanAmerican |
7.540000E-02 |
| Normal-vs-Asian |
7.449400E-04 |
| Caucasian-vs-AfricanAmerican |
3.508200E-01 |
| Caucasian-vs-Asian |
9.138400E-01 |
| AfricanAmerican-vs-Asian |
3.790000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37759999963016E-07 |
| Normal-vs-Female |
1.204670E-04 |
| Male-vs-Female |
2.307700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.015650E-03 |
| Normal-vs-Age(41-60Yrs) |
1.374260E-04 |
| Normal-vs-Age(61-80Yrs) |
2.3032999999506E-06 |
| Normal-vs-Age(81-100Yrs) |
1.992250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.295600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.901800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.419800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.244200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.073000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.408400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.255600E-01 |
| Classical-VS-Follicular |
2.655400E-01 |
| Classical-VS-Other |
1.921400E-01 |
| Classical-VS-Normal |
3.022300E-04 |
| Tall-VS-Follicular |
8.638400E-01 |
| Tall-VS-Other |
4.995800E-01 |
| Tall-VS-Normal |
3.996600E-04 |
| Follicular-VS-Other |
5.988000E-01 |
| Follicular-VS-Normal |
5.385200E-04 |
| Other-VS-Normal |
9.440600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82339999999348E-05 |
| Normal-vs-N1 |
3.63759999999491E-06 |
| N0-vs-N1 |
2.222200E-01 |
|
|
